top of page
Subscribe
Latest
All News
Podcast
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Headlines
Log In
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Egyptian survey reveals trends in bariatric surgery practices
Ring-augmented procedures for revisions and conversions
Research
Allurion Program increases muscle mass and decreases fat mass
A presentation of a study entitled “The swallowable gastric balloon program with AI powered health coach leads to metabolically healthy...
MyPhenome test can predict recurrent weight regain after bariatric surgery
A new study presented by Mayo Clinic researchers at Digestive Disease Week (DDW) has found that the MyPhenome test can help providers...
GLP-1ra receptor agonists role in the management of obesity in Australia
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the...
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...
Transcranial magnetic stimulation combined with cognitive training curbs impulsive eating
Scientists at the Mind, Brain, and Behavior Research Center at the University of Granada (CIMCYC, UGR), Spain, have revealed how - when...
Brain nerve cells control the beneficial effects of semaglutide
Researchers at the Sahlgrenska Academy at the University of Gothenburg have shown that it is possible to distinguish the nerve cells in...
GLORY-1 outcomes shows positive results for mazdutide - a dual glucagon GCG-1/GLP-1 receptor agonist
The results from GLORY-1 - a Phase 3 clinical study of mazdutide - a dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor...
Download Bariatric News issue 55
Issue 55 of Bariatric News is now available to read and/or download. In this issue, we report on the latest outcomes from the...
Journal Watch 21/5/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Egyptian survey reveals trends in bariatric surgery practices
A survey of Egyptian metabolic and bariatric surgeons (MBS) has revealed that procedural volumes are increasing, although economic...
Australian bariatric surgery under threat due to soaring insurance costs
An alarming number of Australian bariatric surgeons are considering shutting their clinics because of skyrocketing insurance costs and...
Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Novo Nordisk and Septerna have announced an exclusive global collaboration and license agreement to discover, develop and commercialise...
Industry
Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Fractyl Health submits of CTA module in Europe for RJVA-001
Bariatric Solutions International's 20th Anniversary Supplement
FDA accepts filing application for oral semaglutide 25mg
All caught up?
See all news
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Browse directory
Events
(See all)
30 May 2025
3rd Annual International Symposium on Magnetic Gastrointestinal and Colon Surgery
View details
8 September 2025
Sixth IBC Oxford University World Congress 2025
View details
27 November 2025
6th London International Bariatric Surgery Symposium (LIBSS)
View details
16 June 2025
16th BOMSS Annual Scientific Meeting
View details
9 September 2025
XXVIII IFSO World Congress
View details
Tweets
Back to Top
bottom of page